Abstract. Humans and other mammals continue to be exposed to various forms of mercury in the environment. The kidneys, specifically the epithelial cells lining the proximal tubules, are the primary targets where mercuric ions accumulate and exert their toxic effects. Although the actual mechanisms involved in the transport of mercuric ions along the proximal tubule have not been defined, current evidence implicates mercuric conjugates of cysteine, primarily 2-amino-3-(2-amino-2-carboxyethylsulfanylmercuricsulfanyl)propionic acid (Cys-S-Hg-S-Cys), as the most likely transportable species of inorganic mercury (Hg 2ϩ ). Because Cys-S-Hg-S-Cys and the amino acid cystine (Cys-S-S-Cys) are structurally similar, it was hypothesized that Cys-S-Hg-S-Cys might act as a molecular mimic of cystine at one or more of the amino acid transporters involved in the luminal absorption of this amino acid. One such candidate is the Na ϩ -independent heterodimeric transporter system b 0,ϩ . Therefore, the transport of Cys-S-Hg-S-Cys and cystine was studied in MDCK II cells that were or were not stably transfected with b 0,ϩ AT-rBAT. Transport of Cys-S-Hg-S-Cys and cystine across the luminal plasma membrane was similar in the transfected cells, indicating that Cys-S-Hg-S-Cys can behave as a molecular mimic of cystine at the site of system b 0,ϩ . Moreover, only the b 0,ϩ AT-rBAT transfectants became selectively intoxicated during exposure to Cys-S-Hg-S-Cys. These findings indicate that system b 0,ϩ likely contributes to the nephropathy induced by Hg 2ϩ in vivo. These data represent the first direct molecular evidence for the participation of a specific transporter in the luminal uptake of a large divalent metal cation in proximal tubular cells.
the Na ϩ -independent heterodimeric transporter system b 0,ϩ . Therefore, the transport of Cys-S-Hg-S-Cys and cystine was studied in MDCK II cells that were or were not stably transfected with b 0,ϩ AT-rBAT. Transport of Cys-S-Hg-S-Cys and cystine across the luminal plasma membrane was similar in the transfected cells, indicating that Cys-S-Hg-S-Cys can behave as a molecular mimic of cystine at the site of system b 0,ϩ . Moreover, only the b 0,ϩ AT-rBAT transfectants became selectively intoxicated during exposure to Cys-S-Hg-S-Cys. These findings indicate that system b 0,ϩ likely contributes to the nephropathy induced by Hg 2ϩ in vivo. These data represent the first direct molecular evidence for the participation of a specific transporter in the luminal uptake of a large divalent metal cation in proximal tubular cells.
A large body of evidence indicates that the epithelial cells lining the convoluted and straight segments of the proximal tubule are the primary sites where inorganic mercury (Hg 2ϩ ) is taken up and accumulated in vivo (1, 2) . Although the actual mechanisms by which mercuric ions are taken up by these cells are not well defined, a number of recent in vivo findings indicate that the uptake of Hg 2ϩ at the luminal membrane of proximal tubular cells is dependent on the activities of the brush border enzymes ␥-glutamyltransferase (3-8) and cysteinylglycinase (8) . It seems that mercuric conjugates of GSH, while in the lumen of the proximal tubule, are degraded sequentially by these enzymes to yield a cysteine-S-conjugate of mercury, primarily 2-amino-3-(2-amino-2-carboxyethylsulfanylmercuricsulfanyl)propionic acid (Cys-S-Hg-S-Cys) (2) . This conjugate is thought to be the principal species of Hg 2ϩ taken up at the luminal plasma membrane of proximal tubular epithelial cells (3) (4) (5) (6) (7) (8) .
Recent studies using brush border membrane vesicles (9) and isolated perfused proximal tubular segments (8, 10) indicate that Cys-S-Hg-S-Cys is indeed transported across the luminal membrane of proximal tubular epithelial cells. Moreover, competitive inhibition experiments using isolated perfused proximal tubular segments have implicated amino acid transporters as the main carrier proteins involved in the absorption of Cys-S-Hg-S-Cys from the proximal tubular lumen (8, 10) .
Interestingly, the molecular structure of Cys-S-Hg-S-Cys is very similar to that of the amino acid cystine (Cys-S-S-Cys). This structural similarity, and the fact that amino acid transporters have been implicated in the luminal uptake of Hg 2ϩ , led us to hypothesize that Cys-S-Hg-S-Cys can act as a "molecular mimic," or homolog of cystine, and can be taken up into proximal tubular cells via one or more of the luminal transporters of cystine. Current evidence indicates that both Na ϩ -dependent and Na ϩ -independent mechanisms are involved in the absorptive luminal transport of Cys-S-Hg-S-Cys in the proximal tubule (10) . Moreover, preliminary data indicate that the Na ϩ -dependent component of Cys-S-Hg-S-Cys transport may be mediated by system(s) ASC and/or B 0,ϩ , whereas a likely candidate for the Na ϩ -independent uptake of Cys-S-Hg-S-Cys is system b 0,ϩ (8) . System b 0,ϩ is a heterodimeric amino acid transporter that is composed of a light chain, b 0,ϩ AT, and a heavy chain, rBAT (11, 12) . More importantly, this amino acid transporter has a high affinity for cystine (11, 12) and, in the kidneys, is localized exclusively in the luminal plasma membrane of the target epithelial cells, i.e., proximal tubular cells (13) (14) (15) . On the basis of these characteristics, we hypothesize that system b 0,ϩ is capable of transporting mercuric ions, in the form of Cys-S-Hg-S-Cys, into the intracellular compartment of renal epithelial cells.
To test this hypothesis, we studied the kinetics and characteristics of the transport of Cys-S-Hg-S-Cys in MDCK II cells that were or were not stably transfected with system b 0,ϩ . These cells represent an immortalized line of renal epithelial cells derived from the distal nephron of a dog and were used for these experiments because they do not normally express b 0,ϩ AT or rBAT. Biochemical data from this study clearly indicate that Hg 2ϩ , in the form of Cys-S-Hg-S-Cys, is a transportable substrate of system b 0,ϩ . Furthermore, our toxicity data indicate that this transporter may contribute to the proximal tubular nephropathy induced by Hg 2ϩ in vivo. This study is the first to provide direct molecular evidence that a specific amino acid transport system, namely, system b 0,ϩ , is involved in the absorptive transport of a biologically relevant molecular species of Hg 2ϩ (i.e., Cys-S-Hg-S-Cys).
Materials and Methods

Tissue Culture and Stable Transfection
The details of the transfection of MDCK II cells with mouse b 0,ϩ AT and human rBAT (b 0,ϩ AT-rBAT transfectants) were described previously (16) . Transfectants were cultured in Dulbecco's modified Eagle's medium (Mediatech, Herndon, VA) supplemented with 10% FBS (Atlanta Biologicals, Atlanta, GA), 100 U/ml penicillin, 100 g/ml streptomycin, 1% essential amino acids, 200 g/ml geneticin, and 150 g/ml hygromycin B (Invitrogen, Carlsbad, CA), as described previously (16) . Wild-type cells were cultured in the same medium without geneticin or hygromycin B.
Reverse Transcription-PCR
Total RNA was isolated from the cells with the use of TRIzol reagent (Invitrogen), according to the manufacturer's instructions. Reverse transcription-PCR analyses were performed with a GeneAmp kit (Applied Biosystems, Foster City, CA). The presence of mouse b 0,ϩ AT and human rBAT was assayed with primers specific for each subunit, yielding 589-bp and 600-bp fragments, respectively (16) .
Laser Scanning Confocal Microscopy
Immunohistochemical experiments were performed as described previously (16) . Briefly, cells were incubated with a polyclonal antibody against mouse b 0,ϩ AT (16) (1:500), followed by incubation with 1 g/ml Texas Red-labeled anti-rabbit IgG Fab fragments (Rockland, Gilbertsville, PA). Cells were then incubated with a polyclonal antibody against human rBAT (16) (1:50), followed by incubation with FITC-labeled anti-rabbit IgG antibody (Sigma Chemical Co., St. Louis, MO). Analyses of the cell monolayers were performed with a Leica laser scanning confocal microscope (TCSSP, Wetzlar, Germany).
Manufacture of 203
Hg 2ϩ
Three milligrams of mercuric oxide were doubly sealed in quartz tubing with an acetylene torch. The relative concentrations of the various isotopes of mercury in the sample of mercuric oxide were as follows: Ͻ0.05% . After removal of the outer quartz tube, the inner tube was crushed and rinsed with four 50-l washes of 1 N HCl. All rinses were placed in a single polypropylene vial. To determine the exact solid content of mercury, a sample of the solution was subjected to plasma-coupled elemental mass spectrometry. The radioactivity of the solution was determined with a Perkin Elmer Wallac Wizard 3 automatic gamma counter (Perkin Elmer, Gaithersburg, MD). The specific activities of the 203 Hg ranged from 6 to 12 mCi/mg (17) .
Evaluation of Transport
Uptake measurements were performed as described previously, with minor changes (18, 19) . Wild-type and transfected MDCK cells were seeded in 24-well plates, at a density of 0.2 ϫ 10 6 cells/well, and were cultured for 24 h before the experiments. Transfectants were cultured in the presence of 1 M dexamethasone, to induce the expression of rBAT (16) . At the beginning of each experiment, culture medium was removed and cells were washed with warm uptake buffer (25 mM Hepes, 140 mM Tris, N-methyl-D-glucamine chloride, 5.4 mM KCl, 1.8 mM CaCl 2 , 0.8 mM MgSO 4 , 5 mM glucose, pH 7.5). Uptake was initiated with the addition of 250 l of uptake buffer containing radiolabeled substrates. Cells were incubated for 30 min at 37°C, unless otherwise stated. Uptake was terminated with the aspiration of radiolabeled compounds, followed by the addition of icecold uptake buffer containing 1 mM sodium 2,3-dimercaptopropane-1-sulfonate (Sigma), a well known mercury chelator (2) . Cells were washed twice with 2,3-dimercaptopropane-1-sulfonate and solubilized with 1% SDS in 0.2 N NaOH, and the radioactivity in the cells was determined by liquid scintillation counting.
To fully characterize the transport processes in MDCK II cells, the uptake of 35 . With the exception of cystine, all amino acids were used at a concentration of 3 mM. Because of low solubility, the highest attainable concentration of cystine was 1 mM.
In addition, 5 M Hg 2ϩ (as mercuric chloride, HgCl 2 ) was presented to the cells, for 30 min at 37°C, as a conjugate of cysteinylglycine (CysGly), N-acetylcysteine (NAC), or GSH. These conjugates were generated as described above for the generation of Cys-S-Hg-S-Cys. NAC-S-Hg-S-NAC was used as a negative control, because it is a highly polar molecule that is not taken up at the luminal plasma membrane of any renal epithelial cell. Mercuric conjugates of CysGly and GSH were used in this study because they are present in the proximal tubule lumen and are considered to be precursors of Cys-S-Hg-S-Cys.
Efflux Assays
Assays measuring the efflux of cystine were performed by preexposing both cell types to 1 mM cystine (containing 35 S) for 10 min at 37°C, followed by a 1-min incubation with 1 mM unlabeled cystine, Cys-S-Hg-S-Cys, glutamate, or arginine or uptake buffer. The extracellular fluid was then placed in scintillation vials for counting. Cells were washed twice with ice-cold buffer and solubilized with 1% SDS/0.2 N NaOH. The content of 35 S in the extracellular fluid and in the cells were determined with liquid scintillation counting.
Assessment of Cellular Viability
The toxicologic effects of HgCl 2 , Cys-S-Hg-S-Cys, and GSH-S-Hg-S-GSH were measured with a methylthiazoletetrazolium assay, as described previously (17) . Wild-type and transfected MDCK cells were seeded at a density of 0.2 ϫ 10 6 cells/ml in 96-well culture dishes (200 l/well). Cells were cultured for 24 h, washed twice with warm uptake buffer, and then were treated with HgCl 2 , (1, 5, 10, 15, or 25 M), Cys-S-Hg-S-Cys (100, 250, 500, 750, or 1000 M), or GSH-S-Hg-S-GSH (100, 250, 500, 750, or 1000 M) for 24 h at 37°C, in a humidified atmosphere of 5% CO 2 . Cells were then washed twice with warm uptake buffer and incubated with 0.5 mg/ml methylthiazoletetrazolium for 2 h at 37°C, in a humidified atmosphere of 5% CO 2 . After this incubation, solubilization buffer (10% Triton X-100 and 0.1 N HCl in isopropyl alcohol) was added to each well and the mixture was allowed to incubate for 16 h at room temperature. Each plate was read at 595 nm with a Titertek Multiskan MKII plate reader (Fisher Scientific, Suwanee, GA).
Data Analyses
All experiments were performed at least twice, with quadruplicate measurements for each condition. Data for each assessed parameter were analyzed first with the Kolmogorov-Smirnov test for normality and then with the Levene test for homogeneity of variances. The data were then analyzed with two-way ANOVA. Tukey's multiple-comparison procedure was used to assess differences among the means. Data expressed as a percentage of a total were normalized with the arc sine transformation before any parametric statistical analysis. This transformation calculates the arc sine of the square root of the decimal fraction of the percentage value. A P value of Ͻ0.05 was considered statistically significant. AT and human rBAT colocalized on the apical plasma membrane, as evidenced by the presence of yellow fluorescence (Figure 2A) . Omission of the primary antibody against human rBAT served as a negative control experiment ( Figure 2B ).
Results
Expression of System b 0,ϩ in Cultured MDCK II Cells
Transport of Cystine and Hg 2ϩ (as Cys-S-Hg-S-Cys)
Time-course analyses demonstrated that the uptake of cystine ( Figure 3A ) and Hg 2ϩ , as Cys-S-Hg-S-Cys ( Figure 3B ), increased in both wild-type and transfected cells with time. The levels of uptake of both compounds were significantly greater in the transfectants at almost every time point studied.
The saturation kinetics for the uptake of cystine ( Figure 4A ) and Hg 2ϩ , as Cys-S-Hg-S-Cys ( Figure 4B ), were analyzed in b 0,ϩ AT-rBAT-transfected cells. When cystine was used as the substrate, the maximal velocity (V max ) of transport increased from 0.14 Ϯ 0.08 nmol/mg protein per min in wild-type cells to 2.5 Ϯ 0.5 nmol/mg protein per min in the transfectants. The The temperature dependence of system b 0,ϩ activity was measured by analyzing the saturation kinetics for the uptake of cystine ( Figure 5A ) and Hg 2ϩ , as Cys-S-Hg-S-Cys ( Figure 5B ), in both cell types at 4°C and 37°C. The uptake of both substrates at 37°C was significantly greater in the transfectants than in corresponding groups of wild-type cells. When the experimental temperature was maintained at 4°C, there were no significant differences in the accumulation of cystine or Cys-S-Hg-S-Cys in corresponding groups of transfected and wild-type cells. Moreover, the amounts of substrate associated with either cell type at 4°C were similar to those associated with wild-type cells at 37°C.
The substrate specificity for the transport of cystine ( Figure  6A ) and Hg 2ϩ , as Cys-S-Hg-S-Cys ( Figure 6B ), was measured in wild-type cells and b 0,ϩ AT-rBAT transfectants. The uptake of cystine in the transfectants was significantly reduced in the presence of unlabeled cystine, cysteine, arginine, leucine, histidine, lysine, phenylalanine, or cycloleucine. The amino acids glutamate and aspartate, which are not substrates of system b 0,ϩ , did not significantly alter the transport of cystine. With the exception of cells treated with cysteine or glutamate, there were no significant differences in the uptake of cystine among the groups of wild-type cells studied. This pattern of amino acid inhibition is in agreement with that demonstrated previously (16, 21, 22) .
The pattern of substrate specificity for the transport of Cys-S-Hg-S-Cys was similar to that for cystine ( Figure 6B ). The uptake of Cys-S-Hg-S-Cys in the transfectants was significantly reduced by arginine, leucine, histidine, lysine, phenylalanine, and cycloleucine. The amino acids glutamate and aspartate did not significantly alter the transport of Cys-S-Hg-S-Cys. In wild-type cells, the presence of additional amino acids, with the exception of cysteine, did not significantly alter the transport of Cys-S-Hg-S-Cys. Interestingly, incubation with unlabeled cystine resulted in a twofold increase in the uptake of Cys-Hg-Cys in the transfectants. This stimulation was proportional to the concentration of cystine used ( Figure 7A ) and was independent of the period of incubation (data not shown). When the uptake of cystine (containing 35 S) was measured in the presence of excess Cys-S-Hg-S-Cys, transport in the transfectants was significantly inhibited ( Figure 7B) .
In a control experiment, the uptake of [ 3 H]arginine and [ 3 H]lysine, which are both substrates for system b 0,ϩ , was measured in the presence and absence of unlabeled cystine. Exposure to cystine inhibited the transport of both lysine and arginine in the transfected cells but did not significantly alter the uptake of these amino acids in wild-type cells (data not shown).
Efflux Assays
Efflux assays were performed with wild-type cells and b 0,ϩ AT-rBAT transfectants, to determine whether unlabeled Cys-S-Hg-S-Cys, cystine, arginine, or lysine was able to stimulate the efflux of [
35 S]cystine/[ 35 S]cysteine (some of the cystine may be reduced intracellularly) ( Figure 8A ). The efflux of 35 S from the transfectants was greatest when cells were treated with Cys-S-Hg-S-Cys (123.2 Ϯ 8.0 nmol/mg per min). This efflux was significantly greater than that in corresponding cells exposed to cystine (89.6 Ϯ 2.2 nmol/mg per min) or arginine (86.4 Ϯ 1.6 nmol/mg per min). The efflux of 35 S was even lower when the extracellular fluid consisted of uptake buffer alone (37.8 Ϯ 4.5 nmol/mg per min) or contained glutamate (26.0 Ϯ 1.6 nmol/mg per min). The mean levels of uptake did not differ significantly between the buffer and glutamate groups. When the cellular content of 35 S were measured, the pattern of uptake corresponded inversely to the pattern of efflux described above, i.e., with greater efflux, lower cellular content of 35 S was observed ( Figure 8B ). There were no significant differences in the efflux or cellular contents of 35 S among the treatment groups of wild-type cells.
Transport of Mercuric Conjugates of Thiol-Containing Biologic Molecules
The uptake of Hg 2ϩ as a mercuric conjugate of cysteine (Cys-S-Hg-S-Cys), NAC (NAC-S-Hg-S-NAC), CysGly (CysGly-S-Hg-S-CysGly), or glutathione (GSH-S-Hg-S-GSH) was measured in wild-type cells and transfectants ( Figure 9 ). There 100 M) , respectively. Results are presented as means Ϯ SEM. Data represent three experiments performed in quadruplicate. *, significantly different (P Ͻ 0.05) from the mean for the corresponding group of wild-type cells; ϩ, significantly different from the mean for the same cell type at the initial concentration; ϩϩ, significantly different from the mean for the same cell type at each of the preceding concentrations; ϩϩϩ, significantly different from the mean for the same cell type at each of the preceding concentrations; ϩϩϩϩ, significantly different from the mean for the same cell type at each of the preceding concentrations.
were no significant differences in the uptake of Hg 2ϩ between corresponding groups of wild-type and transfected MDCK II cells when they were exposed to NAC-S-Hg-S-NAC, CysGly-S-Hg-S-CysGly, or GSH-S-Hg-S-GSH. In contrast, when the transfectants were exposed to Cys-S-Hg-S-Cys, the uptake of Hg 2ϩ was at least twofold greater than that in the corresponding group of wild-type cells.
Cellular Viability Assays
To determine the relationship between cellular transport and intoxication, the viability of wild-type and transfected cells exposed to various species of Hg 2ϩ was assessed. After a 24-h exposure to 100 M Cys-S-Hg-S-Cys, the viability of the b 0,ϩ AT-rBAT transfectants was reduced by 12%, whereas exposure to 1 mM Cys-S-Hg-S-Cys decreased the viability of those cells by 78% ( Figure 10A ). Cellular viability was not significantly affected in corresponding wild-type cells. Treatment with 5 M Cys-S-Hg-S-Cys for 30 min (the experimental conditions used to study various characteristics of transport) did not significantly reduce the viability of either cell type (data not shown). Incubation with GSH-S-Hg-S-GSH also did not alter the viability of the cells at any concentration studied ( Figure 10B ). Because HgCl 2 has been demonstrated to induce cell death in any cultured cell, it was used as a positive control. The viability of both cell types began to decline with 1 M 0,ϩ AT-rBAT-transfected cells. Uptake was measured in the presence of unlabeled cystine (25 to 500 M) or Cys-S-Hg-SCys (1 to 100 M), respectively, at 37°C or 4°C. Results are presented as means Ϯ SEM. Data represent three experiments performed in quadruplicate. *, significantly different (P Ͻ 0.05) from the mean for the corresponding groups of wild-type cells at 4°C and 37°C and significantly different from the mean for the corresponding group of transfected cells at 4°C; ϩ, significantly different from the mean for the transfectants at the initial concentration at 37°C; ϩϩ, significantly different from the mean for the transfectants at each of the preceding concentrations at 37°C; ϩϩϩ, significantly different from the mean for the transfectants at each of the preceding concentrations at 37°C; ϩϩϩϩ, significantly different from the mean for the transfectants at each of the preceding concentrations at 37°C. HgCl 2 and continued to decline with increasing concentrations of HgCl 2 ( Figure 10C ).
Discussion
Because of the growing problem of worldwide contamination of the environment with mercury (23) and the continued use of mercury-containing compounds in industry, medicine, and dentistry, there is an increasing need to better understand how the various chemical forms of this metal are handled by human subjects and other mammals. To truly comprehend how mercury induces its deleterious effects in particular organisms, it is necessary to first understand the mechanisms by which mercuric ions enter the target cells.
In this study, we tested the hypothesis that Cys-S-Hg-S-Cys is an important, biologically relevant species of Hg 2ϩ that acts as a molecular mimic of the amino acid cystine and is transported by the Na ϩ -independent transporter system b 0,ϩ . The rationale for studying Cys-S-Hg-S-Cys rather than other mercuric conjugates is that Cys-S-Hg-S-Cys is the form of Hg 2ϩ most likely presented to the luminal plasma membrane of proximal tubular epithelial cells in vivo (2) . Furthermore, this study focused on the activity of system b 0,ϩ because this . Cells were exposed to 1 mM cystine for 10 min at 37°C and then incubated with buffer only or 1 mM unlabeled cystine, the mercuric conjugate of cysteine (Cys-S-Hg-S-Cys), arginine, or glutamate for 1 min at 37°C. Results are presented as means Ϯ SEM. Data represent two experiments performed in duplicate. *, significantly different (P Ͻ 0.05) from the mean for the corresponding group of wild-type cells; ϩ, significantly different from the mean for the group of transfectants exposed to buffer or glutamate; ϩϩ, significantly different from the mean for the transfectants exposed to buffer, cystine, arginine, or glutamate. the corresponding control cells. The lower K m in the transfectants clearly indicated that another transport system, with a higher affinity for Cys-S-Hg-S-Cys, was mediating most (if not all) of the uptake of this conjugate in the transfected cells. Because the only apparent difference between the wild-type and transfected MDCK II cells was the presence of a functional system b 0,ϩ transporter, it can be concluded that b 0,ϩ AT-rBAT can mediate the absorptive transport of Cys-S-Hg-S-Cys. A small amount of Hg 2ϩ was associated with wild-type cells exposed to Cys-S-Hg-S-Cys, which likely represents nonspecific binding and/or uptake via another mechanism.
Analysis of substrate specificity provided substantive support for our hypothesis that Cys-S-Hg-S-Cys can behave as a functional molecular mimic of cystine at the site of system b 0,ϩ . Substrates of system b 0,ϩ inhibited the transport of both cystine and Cys-S-Hg-S-Cys, whereas amino acids that are not substrates of this transporter did not affect the uptake of either compound. Therefore, the same carrier (i.e., system b 0,ϩ ) can mediate the uptake of both cystine and Cys-S-Hg-S-Cys.
Surprisingly, when the uptake of Cys-S-Hg-S-Cys was assessed in the presence of excess cystine, the inward transport of Cys-S-Hg-S-Cys was actually stimulated twofold or more in the transfectants. This stimulation was proportional to the concentration of cystine used and was independent of the period of incubation (1 to 30 min; data not shown). As the concentration of unlabeled cystine in the extracellular medium increased, the uptake of Cys-S-Hg-S-Cys in the transfectants increased. The cystine-induced stimulation of Cys-S-Hg-S-Cys uptake was specific for this mercuric conjugate. Uptake of other substrates of system b These findings indicate that the presence of excess cystine somehow increases the rate of Cys-S-Hg-S-Cys transport, which is relatively low in the presence of other substrates of system b 0,ϩ . This enhancement in transport activity could be attributable to efficient exchange of cystine for Cys-S-Hg-SCys at the intracellular binding site of system b 0,ϩ , which . The form of Hg 2ϩ that is most likely presented to the luminal membrane of proximal tubular epithelial cells in vivo is a conjugate of cysteine, primarily in the form of Cys-S-Hg-S-Cys. As shown in this model, the molecular structure of Cys-S-Hg-S-Cys is very similar to that of the amino acid cystine (Cys-S-S-Cys). Given the structural similarity of cystine and Cys-S-Hg-S-Cys, it is probable that a transport system with a high affinity for cystine mediates the uptake of both compounds. We postulate that a likely candidate for this uptake is system b 0,ϩ . This carrier is an amino acid exchanger that mediates the transport of cystine, as well as a variety of neutral and cationic amino acids. As a heterodimeric transporter, it is composed of two subunits, b 35 S contents were observed. Therefore, we conclude that the efflux effect observed in the transfectants is attributable specifically to the activity of system b 0,ϩ . These data are consistent with the hypothesis that cystine is exchanged intracellularly for Cys-S-Hg-S-Cys, which facilitates the intracellular release of this conjugate. A diagrammatic representation of this exchange is presented in Figure 11 .
Although it is likely that some of the cystine taken up by the MDCK cells was reduced within the cells, it is not clear whether any of the newly formed cysteine could serve as an exchangeable substrate for system b 0,ϩ . It is unlikely that, if any of the newly formed cysteine was added to the extracellular compartment, this would promote the uptake of cystine, because addition of cysteine to the extracellular compartment was demonstrated to inhibit the uptake of Cys-S-Hg-S-Cys by system b 0,ϩ ( Figure 6B ). Additional studies are clearly required to further characterize this phenomenon.
Transport of Hg 2ϩ in the form of NAC-S-Hg-S-NAC, CysGly-S-Hg-S-CysGly, or GSH-S-Hg-S-GSH was also measured in wild-type cells and transfectants. NAC-S-Hg-S-NAC is a highly polar homolog of Cys-S-Hg-S-Cys that is efficiently transported into proximal tubular epithelial cells from the basolateral extracellular compartment by one or more organic anion transporters (2, 17) . In the lumen, however, the negative charge on each end of the NAC-S-Hg-S-NAC complex is thought to impede or prevent absorption of this mercuric conjugate across the luminal plasma membrane of renal epithelial cells lining the nephron and collecting ducts. Mercuric conjugates of NAC were used as negative controls in this study, to confirm that the polar nature of NAC-S-Hg-S-NAC prevents its absorption at the luminal plasma membrane of renal epithelial cells, although NAC-S-Hg-S-NAC shares structural homology with Cys-S-Hg-S-Cys. As predicted, when control MDCK II cells or MDCK II cells stably transfected with system b 0,ϩ were exposed to NAC-S-Hg-S-NAC, there was no significant uptake of Hg 2ϩ in either cell type. The rationale for examining the uptake of Hg 2ϩ in the form of GSH-S-Hg-S-GSH or CysGly-S-Hg-S-CysGly is that these conjugates are putatively present in the proximal tubular lumen in vivo and the final degradative product of each of these compounds in the lumen (with the actions of ␥-glutamyltransferase and/or cysteinylglycinase) is Cys-S-Hg-S-Cys (3-6). Because ␥-glutamyltransferase and cysteinylglycinase are essentially absent from the luminal compartment of the distal nephron (24) (from which MDCK II cells are derived), GSH-S-Hg-S-GSH and CysGly-S-Hg-S-CysGly would not be expected to be enzymatically degraded to Cys-S-Hg-S-Cys. As predicted, insignificant levels of uptake of Hg 2ϩ were detected in either cell type exposed to GSH-S-Hg-S-GSH or CysGly-S-Hg-S-CysGly, indicating that neither these conjugates nor NAC-S-Hg-S-NAC, are transportable substrates of system b 0,ϩ . These toxicologic findings indicate that a strong relationship exists between the transport and toxicity of Hg 2ϩ as Cys-SHg-S-Cys in the b 0,ϩ AT-rBAT transfectants. The viability of the transfectants was significantly lower than that of wild-type cells after identical exposures to Cys-S-Hg-S-Cys. Incubation with GSH-S-Hg-S-GSH did not significantly alter the cellular viability of either cell type at any concentration studied. This observation was not surprising, since GSH-S-Hg-S-GSH was not taken up to a significant extent by either cell type. These data indicate that the presence of system b 0,ϩ promotes the uptake of Cys-S-Hg-S-Cys into the intracellular compartment of these cells, which eventually results in cell death.
In conclusion, the results of this study demonstrate for the first time that Cys-S-Hg-S-Cys is indeed a transportable substrate of system b 0,ϩ ( Figure 11 ). Moreover, these results implicate a mechanism of molecular mimicry, with Cys-S-Hg-S-Cys mimicking the amino acid cystine at the site of system b 0,ϩ . The transport and toxicologic findings from this study also indicate that system b 0,ϩ likely plays a significant role in the nephropathy induced by in vivo exposure to Hg 2ϩ , by mediating the uptake of a transportable species of Hg 2ϩ , Cys-S-Hg-S-Cys, into proximal tubular epithelial cells.
